The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells

Proceedings of the National Academy of Sciences of the United States of America
M H HansenH J Ditzel

Abstract

Medullary carcinoma of the breast (MCB) is a morphologically and biologically distinct subtype of human breast cancer that, despite cytologically anaplastic features, has a more favorable prognosis than other types of breast cancer at similar stages of differentiation. It has been proposed that the improved clinical outcome is due, at least in part, to the presence of a prominent lymphoplasmacytic cell infiltrate in the tumor stroma. We studied the B lymphoplasmacytic cell infiltrates in MCB to determine the role of the antibody response produced by the local infiltrating cells. Oligoclonal predominance among tumor-infiltrating B cells in a panel of MCB patients was observed, suggesting that certain B cell clones were expanded, possibly in response to specific tumor-associated stimuli. IgG antibody phage-display libraries were generated from MCB-infiltrating lymphoplasmacytic cells of two patients, and MCB-reactive monoclonal antibodies were retrieved by selection on fresh-frozen MCB tissue sections. Analysis by mass spectrometry revealed that the antigen targeted by the dominant clones in the oligoclonal B lymphoplasmacytic response in both patients was not a cancer-specific antigen but the cytoskeletal protein beta-actin. MCB...Continue Reading

References

Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D R BurtonR A Lerner
Apr 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R J CoteL J Old
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·C KayalarD E Bredesen
Nov 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A J CzajaF B Bianchi
Apr 1, 1997·The Biochemical Journal·S B BrownJ Savill
Jan 24, 1998·Current Opinion in Immunology·T Boon, L J Old
Sep 28, 1999·The Journal of Experimental Medicine·L Casciola-RosenA Rosen
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·H J DitzelD R Burton

❮ Previous
Next ❯

Citations

Jun 9, 2004·Cancer Immunology, Immunotherapy : CII·Christian KerstenAlexander Fosså
Jul 23, 2011·Cancer Immunology, Immunotherapy : CII·Andrea LadányiJózsef Tímár
Mar 30, 2007·Breast Cancer Research and Treatment·Y WangR P Junghans
Jun 15, 2011·Breast Cancer Research and Treatment·S M A MahmoudA R Green
Oct 16, 2003·Current Opinion in Pharmacology·O H Brekke, G Å Løset
Jul 11, 2003·Progress in Retinal and Eye Research·Bob MeekRon Peek
Jan 16, 2010·Cell Death and Differentiation·E Darrah, A Rosen
Feb 9, 2005·DNA and Cell Biology·Yue-Jin WenThomas Kieber-Emmons
Jan 27, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A SağlamA H Uner
Mar 24, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Theresa L Whiteside, Soldano Ferrone
Mar 17, 2012·Breast Cancer Research : BCR·Shuzhen LiuTorsten O Nielsen
Aug 7, 2004·The Tohoku Journal of Experimental Medicine·Kazuyuki InoueToshio Suzuki
Dec 11, 2013·Mediators of Inflammation·Elisabetta ProfumoRachele Riganò
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·F Stephen HodiGlenn Dranoff
Apr 4, 2014·Cancer Immunology, Immunotherapy : CII·Karīna SiliņaAija Linē
Oct 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·Danielle B UlanetAntony Rosen
Jun 21, 2012·Cancer Investigation·Olga KostianetsRamziya Kiyamova
Mar 18, 2004·International Journal of Cancer. Journal International Du Cancer·Francesca Di ModugnoPaola Nisticò
Sep 1, 2014·The American Journal of Pathology·Tadahiro KobayashiTakashi Matsushita
May 19, 2011·European Journal of Immunology·Marzena CiechomskaAndrew M Knight
Jun 20, 2006·International Immunopharmacology·Gabriel FiszmanMaría Elena Sales
Apr 13, 2004·Seminars in Diagnostic Pathology·John H Eichhorn
Jan 15, 2004·The Journal of Clinical Investigation·Pascal KahlemClemens A Schmitt
May 28, 2010·MAbs·Roger R Beerli, Christoph Rader
Jun 24, 2016·Journal of the National Cancer Institute·Michael D IglesiaBenjamin G Vincent
Mar 15, 2011·Autoimmunity Reviews·Vito RacanelliFederico Perosa
Dec 8, 2009·Autoimmunity Reviews·Ana LleoM Eric Gershwin
Sep 30, 2016·International Journal of Cancer. Journal International Du Cancer·Kaname OhyamaNaotaka Kuroda
Jan 31, 2017·International Journal of Laboratory Hematology·M AlcasidR S Ohgami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.